×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Natco Pharma
Natco Pharma
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
Natco Pharma shares fall post 7 observations from USFDA
Stocks to Watch Today: TCS, Rail Vikas Nigam, Tata Power, HG Infra, Natco Pharma, Lupin, Shilpa Medicare, IDBI Bank in focus on 24 November
Reduce Natco Pharma: target of Rs 750: ICICI Securities
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
Natco Pharma shares fall 3.5% as SC agrees to urgently list Roche's plea on Risdiplam launch
Natco Pharma shares jump 6% after Delhi HC allows firm to sell 'Risdiplam' in India
Stocks to Watch Today: TCS, Tata Elxsi, Natco Pharma, WeWork, Afcons Infra, Lloyds Engineering, NTPC Green Energy, 5Paisa Capital in focus on 10 October
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
Stocks to Watch Today: Infosys, Dr Reddys Labs, Tata Consumer, Cigniti, Force Motors, Natco Pharma, IndusInd Bank, BEML, Tilaknagar Ind in focus on 24 July
Natco Pharma offers to buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore
Natco Pharma plans to acquire majority stake in South Africa-based Adcock Ingram Holdings: CNBC-Awaaz
Natco Pharma shares fall on seven observations from USFDA
Stocks to Watch Today: Sai Life Sciences, Kaynes Tech, GMM Pfaudler, Axiscades Tech, Natco Pharma, ITD Cementation, Oswal Pumps in focus on 20 June
Stocks to Watch Today: ITC, Bajaj Finance, Sun Pharmaceutical, Syngene, Natco Pharma, Vedanta, Sacheerome in focus on 16 June
Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y
Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y
Hold Natco Pharma; target of Rs 890: ICICI Securities
Stocks to Watch Today: SAIL, Avanti Feeds, Insecticides India, Balaji Amines, Cummins, Mishra Dhatu Nigam, IRCTC, Unified Data Tech in focus on 29 May
Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y
Natco Pharma Standalone December 2024 Net Sales at Rs 407.60 crore, down 34.82% Y-o-Y
Natco Pharma shares bleed 18.5% as Q3 earnings show disappoints
Natco Pharma Consolidated September 2024 Net Sales at Rs 1,371.10 crore, up 32.94% Y-o-Y
Natco Pharma Standalone September 2024 Net Sales at Rs 1,292.60 crore, up 38.91% Y-o-Y
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio